Japan Tissue Engineering Co., Ltd. (7774.T)
JPY 457.0
(-2.35%)
JPY 457.0
(-2.35%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.06 Billion JPY | 50.02% |
| 2022 | -4.13 Billion JPY | 16.18% |
| 2021 | -4.93 Billion JPY | 6.48% |
| 2020 | -5.27 Billion JPY | 8.24% |
| 2019 | -5.74 Billion JPY | 2.96% |
| 2018 | -5.92 Billion JPY | 4.4% |
| 2017 | -6.19 Billion JPY | -52.04% |
| 2016 | -4.07 Billion JPY | -6.36% |
| 2015 | -3.83 Billion JPY | 35.49% |
| 2014 | -5.93 Billion JPY | -697.29% |
| 2013 | -744.98 Million JPY | 31.36% |
| 2012 | -1.08 Billion JPY | 47.16% |
| 2011 | -2.05 Billion JPY | 34.55% |
| 2010 | -3.13 Billion JPY | -1576.75% |
| 2009 | -187.16 Million JPY | 87.15% |
| 2008 | -1.45 Billion JPY | 41.01% |
| 2007 | -2.46 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -4.29 Billion JPY | -107.92% |
| 2024 Q2 | -4.03 Billion JPY | 6.04% |
| 2023 Q1 | -4.07 Billion JPY | 1.32% |
| 2023 Q3 | -4.06 Billion JPY | 3.33% |
| 2023 FY | -2.06 Billion JPY | 50.02% |
| 2023 Q2 | -4.2 Billion JPY | -3.02% |
| 2023 Q4 | -2.06 Billion JPY | 49.14% |
| 2022 Q4 | -4.13 Billion JPY | 5.51% |
| 2022 Q3 | -4.37 Billion JPY | 2.66% |
| 2022 Q2 | -4.49 Billion JPY | 5.47% |
| 2022 Q1 | -4.75 Billion JPY | 3.59% |
| 2022 FY | -4.13 Billion JPY | 16.18% |
| 2021 Q4 | -4.93 Billion JPY | 1.12% |
| 2021 Q3 | -4.98 Billion JPY | 3.39% |
| 2021 Q2 | -5.16 Billion JPY | 4.48% |
| 2021 Q1 | -5.4 Billion JPY | -2.49% |
| 2021 FY | -4.93 Billion JPY | 6.48% |
| 2020 FY | -5.27 Billion JPY | 8.24% |
| 2020 Q2 | -5.5 Billion JPY | 4.27% |
| 2020 Q3 | -5.38 Billion JPY | 2.15% |
| 2020 Q4 | -5.27 Billion JPY | 2.09% |
| 2020 Q1 | -5.75 Billion JPY | -0.05% |
| 2019 Q1 | -6.08 Billion JPY | -2.7% |
| 2019 Q2 | -5.8 Billion JPY | 4.53% |
| 2019 Q3 | -5.71 Billion JPY | 1.52% |
| 2019 FY | -5.74 Billion JPY | 2.96% |
| 2019 Q4 | -5.74 Billion JPY | -0.51% |
| 2018 FY | -5.92 Billion JPY | 4.4% |
| 2018 Q2 | -5.82 Billion JPY | 7.74% |
| 2018 Q1 | -6.31 Billion JPY | -1.91% |
| 2018 Q3 | -5.81 Billion JPY | 0.1% |
| 2018 Q4 | -5.92 Billion JPY | -1.78% |
| 2017 Q4 | -6.19 Billion JPY | -3.3% |
| 2017 FY | -6.19 Billion JPY | -52.04% |
| 2017 Q3 | -5.99 Billion JPY | 0.74% |
| 2017 Q2 | -6.04 Billion JPY | -1.72% |
| 2017 Q1 | -5.94 Billion JPY | -45.77% |
| 2016 FY | -4.07 Billion JPY | -6.36% |
| 2016 Q2 | -3.77 Billion JPY | 2.98% |
| 2016 Q3 | -3.75 Billion JPY | 0.57% |
| 2016 Q4 | -4.07 Billion JPY | -8.43% |
| 2016 Q1 | -3.89 Billion JPY | -1.68% |
| 2015 Q1 | -4.4 Billion JPY | 25.83% |
| 2015 FY | -3.83 Billion JPY | 35.49% |
| 2015 Q4 | -3.83 Billion JPY | 3.58% |
| 2015 Q3 | -3.97 Billion JPY | 4.26% |
| 2015 Q2 | -4.15 Billion JPY | 5.79% |
| 2014 Q3 | -6.81 Billion JPY | -1364.85% |
| 2014 Q2 | -464.99 Million JPY | 28.46% |
| 2014 FY | -5.93 Billion JPY | -697.29% |
| 2014 Q1 | -649.96 Million JPY | 12.75% |
| 2014 Q4 | -5.93 Billion JPY | 12.8% |
| 2013 Q3 | -406.14 Million JPY | 40.87% |
| 2013 FY | -744.98 Million JPY | 31.36% |
| 2013 Q2 | -686.91 Million JPY | 25.21% |
| 2013 Q4 | -744.98 Million JPY | -83.43% |
| 2013 Q1 | -918.49 Million JPY | 15.37% |
| 2012 Q2 | -1.51 Billion JPY | 15.95% |
| 2012 Q1 | -1.8 Billion JPY | 11.96% |
| 2012 Q3 | -1.28 Billion JPY | 15.14% |
| 2012 Q4 | -1.08 Billion JPY | 15.85% |
| 2012 FY | -1.08 Billion JPY | 47.16% |
| 2011 Q2 | -2.6 Billion JPY | 9.09% |
| 2011 Q3 | -2.3 Billion JPY | 11.5% |
| 2011 Q4 | -2.05 Billion JPY | 10.87% |
| 2011 FY | -2.05 Billion JPY | 34.55% |
| 2011 Q1 | -2.86 Billion JPY | 8.73% |
| 2010 Q2 | 346.53 Million JPY | 1085.64% |
| 2010 FY | -3.13 Billion JPY | -1576.75% |
| 2010 Q3 | -3.39 Billion JPY | -1079.08% |
| 2010 Q4 | -3.13 Billion JPY | 7.51% |
| 2010 Q1 | 29.22 Million JPY | 115.62% |
| 2009 Q4 | -187.16 Million JPY | -110.02% |
| 2009 Q2 | -368.11 Million JPY | 44.57% |
| 2009 Q1 | -664.12 Million JPY | 54.41% |
| 2009 Q3 | -89.11 Million JPY | 75.79% |
| 2009 FY | -187.16 Million JPY | 87.15% |
| 2008 Q4 | -1.45 Billion JPY | 13.11% |
| 2008 FY | -1.45 Billion JPY | 41.01% |
| 2008 Q3 | -1.67 Billion JPY | 0.0% |
| 2007 FY | -2.46 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 742.75 Million JPY | 378.198% |
| PRISM BioLab Co.,LTD | -1.13 Billion JPY | -82.226% |
| GNI Group Ltd. | -17.93 Billion JPY | 88.478% |
| Linical Co., Ltd. | -4.46 Billion JPY | 53.704% |
| Trans Genic Inc. | -221.16 Million JPY | -834.283% |
| MEDINET Co., Ltd. | -4.39 Billion JPY | 52.974% |
| Soiken Holdings Inc. | -4.79 Billion JPY | 56.862% |
| Cytori Cell Research Institute, Inc. | 1.43 Billion JPY | 244.143% |
| AnGes, Inc. | -3.79 Billion JPY | 45.59% |
| OncoTherapy Science, Inc. | -420.8 Million JPY | -391.043% |
| Nxera Pharma Co., Ltd. | 24.9 Billion JPY | 108.296% |
| Immuno-Biological Laboratories Co., Ltd. | -498.15 Million JPY | -314.8% |
| NanoCarrier Co., Ltd. | -466.34 Million JPY | -343.092% |
| Carna Biosciences, Inc. | -2.7 Billion JPY | 23.642% |
| CanBas Co., Ltd. | -1.88 Billion JPY | -9.435% |
| D. Western Therapeutics Institute, Inc. | -982.14 Million JPY | -110.392% |
| RaQualia Pharma Inc. | -3.39 Billion JPY | 39.172% |
| Chiome Bioscience Inc. | -1.03 Billion JPY | -99.733% |
| Kidswell Bio Corporation | 343.58 Million JPY | 701.4% |
| PeptiDream Inc. | 3.29 Billion JPY | 162.769% |
| Oncolys BioPharma Inc. | -972.59 Million JPY | -112.457% |
| Ribomic Inc. | -2.09 Billion JPY | 1.591% |
| SanBio Company Limited | -3.78 Billion JPY | 45.475% |
| Healios K.K. | -2.19 Billion JPY | 5.646% |
| BrightPath Biotherapeutics Co., Ltd. | -944.85 Million JPY | -118.693% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -2.62 Billion JPY | 21.257% |
| Delta-Fly Pharma, Inc. | -1.41 Billion JPY | -45.819% |
| StemRIM | -8.41 Billion JPY | 75.43% |
| CellSource Co., Ltd. | -4.68 Billion JPY | 55.88% |
| FunPep Company Limited | -1.79 Billion JPY | -15.221% |
| Kringle Pharma, Inc. | -2.13 Billion JPY | 3.283% |
| Stella Pharma Corporation | -1.11 Billion JPY | -84.593% |
| TMS Co., Ltd. | -3.44 Billion JPY | 40.047% |
| Noile-Immune Biotech Inc. | -5.55 Billion JPY | 62.807% |
| Cuorips Inc. | -5.56 Billion JPY | 62.842% |
| K Pharma,Inc. | -3.26 Billion JPY | 36.74% |
| Takara Bio Inc. | -32.2 Billion JPY | 93.583% |
| ReproCELL Incorporated | -2.93 Billion JPY | 29.694% |
| PhoenixBio Co., Ltd. | -660.96 Million JPY | -212.628% |
| StemCell Institute Inc. | -2.83 Billion JPY | 27.158% |
| CellSeed Inc. | -2.01 Billion JPY | -2.699% |